Medical device maker Minnetronix touted its acquisition of privately held Neurofluidics, a company developing treatment for neurological disorders. The details of the merger were not disclosed.
California-based Neurofluidics became a subsidiary of Minnetronix, which Minnetronix president & CEO Rich Nazarian called a "natural fit."
St. Paul, Minn.-based Minnetronix develops and manufactures medical devices for the likes of Medtronic (NYSE:MDT) and St. Jude Medical (NYSE:STJ), but has also been making efforts to develop its own technologies, the Minneapolis/St. Paul Business Journal reported.